2019 Autumn Conference – Includes Joint Day with ECNP
05 – 07 September, 2019 // Hotel Bella Sky, Copenhagen, Denmark
Distinguished Poster Award Recipient: |
||
| The potential benefits of utilizing a standard of care treatment study to prepare participants for enrollment in a treatment resistant depression (TRD) clinical trial (Sauder) | ||
|
All Poster PDFs and Abstracts are available at the end of the second day. |
||
5 September 2019 |
||
| Welcome Reception | ||
6 September 2019
|
||
| Welcome from the Presidents | Carla Canuso Celso Arango  slides video |
|
| Clinical Trials for Treatment Resistant Neuropsychiatric Conditions | Chairs: Phil Harvey Christoph Correll |
|
| Introduction | Christoph Correll Rich Keefe video |
|
| Clinical trials for treatment resistant neuropsychiatric conditions: Lessons from treatment resistant schizophrenia | Oliver Howes slides video |
|
| Methodological issues in treating treatment resistant affective disorders | Mark Weiser slides video |
|
| Regulatory perspectives on treatment resistance | Tiffany Farchione slides video Valentina Mantua* |
|
| Panel / Audience Discussion | Discussant: Tiffany Farchione Speakers video |
|
| Cognitive Challenges in Treatment Trials for Epilepsy and Multiple Sclerosis | Chairs: Jill Rasmussen Christoph Helmstaedter |
|
| Introduction | Jill Rasmussen slides video |
|
| Neuropsychology in epilepsy: Assessment challenges and issues | Christoph Helmstaedter slides video |
|
| Cognition in epilepsy: Issues, challenges, clinical trials to date, next steps | Kimford Meador slides video |
|
| Cognition in multiple sclerosis: Measurement and application to clinical trials | Dawn Langdon slides video |
|
| Regulatory perspective on cognitive challenges in treatment trials for epilepsy and multiple sclerosis | Marion Haberkamp slides video |
|
| Panel / Audience Discussion | Speakers video |
|
| Drug Development for Autism Spectrum Disorder: Challenges and Opportunities | Chairs: Valentina Mantua Tiffany Farchione Celso Arango |
|
| Introduction | Tiffany Farchione video |
|
| Biomarkers in autism spectrum disorder: The Autism Biomarkers Consortium for Clinical Trials | Jamie McPartland slides video |
|
| Personalized medicine in autism spectrum disorders – AIMS2 trials | Declan Murphy slides video |
|
| Role of digital medicine in Autism Spectrum Disorders clinical trials | Gahan Pandina slides video |
|
| Methodological challenges in designing clinical trials for Autism Spectrum Disorders | Evdokia Anagnostou slides video |
|
| The way forward in drug development for Autism Spectrum Disorders | Jeremy Veenstra-Vanderweele slides video |
|
| Regulatory Comment | Tiffany Farchione slides video Valentina Mantua* |
|
| Panel Discussion – including family members/patient associations | video |
|
| Concluding remarks | Celso Arango video |
|
| Joint meeting adjournment | Carla Canuso Celso Arango |
|
| ISCTM Poster Session | Poster PDFs and Abstracts | |
7 September 2019 |
||
| Developing Pharmacological Treatments for the Rapid Reduction of Suicidal Ideation in Depression | Chairs: Carla Canuso Philippe Courtet Suresh Durgam |
|
| Introduction | Carla Canuso slides video |
|
| Is suicidal depression a specific phenotype? | Philippe Courtet slides video |
|
| Unique methodological considerations in this novel indication | Jerry Sanacora slides video |
|
| Moderated Panel / Audience Discussion | Moderator: Suresh Durgam slides videoPanelists: Wieslaw Cubala Dong-Jing Fu Jonathan Javitt Emilie Olié |
|
| Biomarkers to enrich and predict response to rapidly acting antidepressants | Elizabeth Ballard slides video |
|
| Ecological momentary assessment (EMA) and machine learning: Digital phenotyping in suicide behavior | Enrique Baca-Garcia slides video |
|
| How can we study the effects of new treatment on suicidal behavior? | Greg Simon slides video |
|
| Regulatory and Payor perspective | Jean Kim slides video Maarten Postma slides video |
|
| Discussion / Summary | ||
| Meeting Adjourns | Carla Canuso video |
|
|
Working Group Sessions |
||
| Artificial Intelligence and Machine Learning for CNS Clinical Trials | Chairs: Larry Alphs Adam Butler slides-summary |
|
| Assessment of Methods and Endpoints for Rapid Acting Antidepressants – RAADs | Chairs: Elizabeth Ballard Christian Yavorsky summary |
|
| Autism Spectrum Disorder | Chairs: Valentina Mantua Tiffany Farchione Celso Arango summary |
|
| Innovative Technologies for Clinical Trials | Chairs: Richard Keefe Mike Davis summary |
|
| Orphan Diseases | Chairs: Gahan Pandina Ravi Anand summary |
|
| * Presentation not released | ||